Technetium-99m(^(99m)Tc)is the most used(>80%)radionuclide in the clinical nuclear diagnostic imaging procedure.The traditional approach to preparing ^(99m)Tc-based imaging agents utilizes stannous chloride(SnCl_(2...Technetium-99m(^(99m)Tc)is the most used(>80%)radionuclide in the clinical nuclear diagnostic imaging procedure.The traditional approach to preparing ^(99m)Tc-based imaging agents utilizes stannous chloride(SnCl_(2))for the reduction of noncomplexing pertechnetate(^(99m)TcO_(4)^(−))to low-valent Tc[e.g.,Tc(IV)].This process,however,is difficult to control precisely and usually results in toxic SnCl_(2) residue and remaining 99mTc(VII),both of which are destructive to humans.Herein,we report a new strategy for preparing^(99m)TcO_(4)^(−)-labeled agents without adding any reductants.The deliberately designed nanoscale cationic polymeric network(SCU-CPN-3)shows excellent affinity for^(99m)TcO_(4)^(−)even at trace levels originating from the strong p-πinteraction with^(99m)TcO_(4)^(−).Impressively,record-fast labeling kinetics are observed,where almost quantitative labeling efficacy(>96%)can be achieved within 1 min,giving rise to a short labeling time and simple operation using a clinical kit.Both single-photon emission computed tomography(SPECT)images and ex vivo biodistribution of different tumor model analyses verify the potential feasibility of this strategy for tumor imaging.展开更多
基金supported by the Intergovernmental International Cooperation of the National Key R&D Program of China(grant no.2022YFE0105300)the National Natural Science Foundation of China(grant nos.21825601,22306136,21790374,22176139,and 22206144)+4 种基金the China National Postdoctoral Program for Innovative Talents(grant no.BX2021206)the China Postdoctoral Science Foundation(grant no.2021M702390)the Natural Science Foundation of Jiangsu(grant no.BK20230510)the National Key R&D Program of China(grant no.2018YFB1900203)the New Cornerstone Science Foundation through the XPLORER PRIZE.
文摘Technetium-99m(^(99m)Tc)is the most used(>80%)radionuclide in the clinical nuclear diagnostic imaging procedure.The traditional approach to preparing ^(99m)Tc-based imaging agents utilizes stannous chloride(SnCl_(2))for the reduction of noncomplexing pertechnetate(^(99m)TcO_(4)^(−))to low-valent Tc[e.g.,Tc(IV)].This process,however,is difficult to control precisely and usually results in toxic SnCl_(2) residue and remaining 99mTc(VII),both of which are destructive to humans.Herein,we report a new strategy for preparing^(99m)TcO_(4)^(−)-labeled agents without adding any reductants.The deliberately designed nanoscale cationic polymeric network(SCU-CPN-3)shows excellent affinity for^(99m)TcO_(4)^(−)even at trace levels originating from the strong p-πinteraction with^(99m)TcO_(4)^(−).Impressively,record-fast labeling kinetics are observed,where almost quantitative labeling efficacy(>96%)can be achieved within 1 min,giving rise to a short labeling time and simple operation using a clinical kit.Both single-photon emission computed tomography(SPECT)images and ex vivo biodistribution of different tumor model analyses verify the potential feasibility of this strategy for tumor imaging.
